Marianna Foldvari

Pharmaceutical scientist, professor, educator, innovator, entrepreneur.

[Young Scientist Committee YSC-CRS @CRS_YSC]

🔔 Reminder! Just a few days to go!
🧠 Join Professors @JustinHanesPhD @MollyShoichet for a dynamic conversation on driving biomedical innovation from the lab to real-world impact
📅 Thursday, 19th June
🕛 12 PM EST
🔗 Free registration: https://t.co/LFSkkjnNYs
@CRSScience

[Controlled Release Society @CRSScience]

We're delighted to announce our first CRS 2025 Plenary Speaker, Robert Langer!

Robert Langer is one of nine Institute Professors at MIT, and he has been cited over 434,000 times with an h-index of 327 – the highest of any engineer in history. In addition, he is a co-founder of several companies including Moderna. He holds 42 honorary doctorates and has received over 220 awards, including the U.S. National Medals of both Science and Technology & Innovation.

Registration for #CRS2025 is coming soon!

[J Controlled Release @JCRnEDITORS]

Physicochemical and structural insights into lyophilized mRNA-LNP from lyoprotectant and buffer screenings.
| Chun-Wan Yen @genentech |
#mRNADelivery #lyoprotectant #buffer
https://t.co/S6Ubc9I2Xy

[J Controlled Release @JCRnEDITORS]

To see or not to see: In vivo nanocarrier detection methods in the brain and their challenges.
| Igor Khalin @ISD_Research | @CRS_GermanChapt
[50 days' free access]
#BrainDeliver #BloodBrainBarrier #biodistribution
https://t.co/C74L2y8jsE

[Editors of Advanced Drug Delivery Reviews @ADDReditors]

ADDR in press: Gene therapy strategies for glaucoma from IOP reduction to retinal neuroprotection: progress towards non-viral systems.
By Marianna Foldvari & coworkers @UWPharmacy @CC_CRS
#genetherapy #nonviralvector #glaucoma
https://t.co/feIgpRn1bs

[Foldvari Research Group @MFoldvari]

Canadian Society for Pharmaceutical Sciences-CRS Annual Meeting is happening in Edmonton @CanadaCSPS @CC_CRS Antoine Hakim from our lab presenting his research on neuroprotective mRNA nanoparticles for glaucoma. @UWPharmacy @CRS_FG_NANO @CRS_FG_Gene Thank you Dr Badea usaskpharm

[Marianna Foldvari @FoldvariCastle]

Geomagnetic storm on May 10, 2024 Friday night; awestruck viewing the Aurora borealis (Merryhill area, Ontario)

[The Nobel Prize @NobelPrize]

"You can't know everything about everything, but you can be a piece of solving things."

Hear physics laureate Arthur McDonald speak about dealing with one's inner doubts.

Watch the full student session with the physics laureate here: https://t.co/4Or46Znfxk

[NanoMedicines Innovation Network @NMIN_NCE]

Call for abstracts | Event: Vancouver Nanomedicine Day 2023 (Nov 15). Speakers include Dr. Pieter Cullis @UBCbiochemistry @UBCChem @UBC, @ColinRossUBC827, @SabrinaRLeslie, @MJMitchell_Lab

Info & register: https://t.co/A0PczWgN4S

[Royal Society of Chemistry @RoySocChem]

What role does pharmaceutics have in building a healthier world? A big one – that’s why we’ve created RSC Pharmaceutics, a new gold open access journal focusing on drug delivery, precision medicine and enhanced drug targeting. Stay tuned for more updates!

[Somatic Cell Genome Editing (SCGE) Outreach @somaticediting]

Learn more about #SCGE investigator Jennifer Doudna in this fantastic interview with @NobHillGazette. Here she discusses the evolution of #CRISPR, it's potential ethical implications, and her road to becoming Nobel laureate!

@doudna_lab @igisci @UCBerkeley

[ChristianaCare Gene Editing Institute @GeneEditingDE]

Epigenetic editing, known as the "younger sister" of gene editing, may help reduce the risk of heart disease in humans by suppressing a gene that is associated with high cholesterol.

Check out other exciting ways of gene therapy to better our health: https://t.co/rJHl1zoKyW

[NanoMedicines Innovation Network @NMIN_NCE]

Catch up with NMIN: July 2023 updates on researchers & trainees, events & other developments in the #NanoMedicines Innovation Network

Read the newsletter: https://t.co/pxIjFMgxZj

@NCE_RCE @UBC @UofT @UofTNews @Nano_Canada @CRS_FG_Gene @CRSScience

[NanoMedicines Innovation Network @NMIN_NCE]

NMIN spin-off NanoVation Therapeutics (Vancouver) is hiring: they seek an innovative Scientist, Formulation to help develop next-generation LNP-based platform technologies for delivering gene therapies. More info: https://t.co/0Ve9gIXreH

[NanoMedicines Innovation Network @NMIN_NCE]

Tomorrow - don't miss it!

[NPR @NPR]

The FDA has approved a controversial new drug for the fatal condition known as ALS, or Lou Gehrig's disease.

The decision is being hailed by patients and their advocates, but questioned by some scientists.

https://t.co/RQepXMtQf5

[MIT Technology Review @techreview]

Inhaled vaccines produce an immune response in the linings of the airways, allowing the body to quickly respond to any virus entering via the nose and mouth. Two have been approved for covid-19, but we don’t know how effective they will be. https://t.co/jaWYzphxtd

[Gates Foundation @gatesfoundation]

Women’s empowerment ➡️ a healthier, more equal world. @Malala #Goalkeepers2030

[Nature Biotechnology @NatureBiotech]

CRISPR method boosts efficiency and yield without viral vectors #NBTintheNews via @GENbio https://t.co/MVoGwfR2kn